Synpromics Ltd.

https://www.synpromics.com

Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data-driven design. The company has developed PromPTÒ, its multi-dimensional bioinformatics database that enables product-specific promoter design and selection empowering the next generation of cell and gene based medicines and bioprocessing applications. The company operates in a diverse range of fields, including broad applications in cell and gene based medicine, biologics manufacturing and viral vector bioprocessing. Current partners include Biomarin, uniQure, AGTC, Solid Bio, Homology Medicines, Inc, Adverum, GE Healthcare and Sartorius-Stedim Cellca, as well as numerous undisclosed partners in the pharmaceutical sector. About Synthetic Promoters Promoters are the natural switches that control the expression of genes into proteins, and are responsible for decoding the genome. Naturally occurring promoters have evolved for biological functions but have limitations when utilised in industrial or therapeutic applications. Synthetic promoters with DNA sequences not found in nature are designed to better regulate gene activity and precisely control protein production. Synpromics creates highly specific promoters designed to drive gene expression at the desired level and specificity in any cell type, tissue or environmental condition. Each synthetic promoter represents a novel invention and thus can be patented. *

	Start	2010-09-10 established
	Group	Bayer (Group)
	Industry	genomic technology
	Industry 2	PromPT® s/w toolkit for promoter design and selection
	Person	Venables, David (Laverock Therapeutics 202309 CEO formerly Synpromics 201508 CEO)
	Person 2	Roberts, Michael L. (Synpromics 201408 CSO + Founder)

	Region	Edinburgh
	Country	United Kingdom (GB)
	Street	Roslin Innovation Centre, East Bush Campus
	City	EH25 9RG Midlothian, Scotland
	Tel	+44-131-651-9662
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Synpromics Ltd.. (1/17/18). "Press Release: Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development. Company Establishes U.S. Subsidiary to Expand Operations". Edinburgh.

		Record changed: 2023-09-28